大家都搜：
赛诺菲（公司名）
1、sanitary meaning───卫生意义
2、old san juan───圣胡安
3、darkner sans───没有帐号？
4、consanguineal kinship───血缘关系
5、courtesan beijing───北京JiNv
6、thousands numbers───数千个数字
7、batture sand───网砂
8、palo santo───圣树
9、SantaC aus───桑塔克来自
10、sanctified zealot───神圣的狂热者
1、WHO officials "are convinced that the seasonal influenza vaccine is just as important, " the Sanofi Pasteur spokesman says.───世卫组织官员确信，”季节性流感疫苗也是同样重要的，“赛诺菲巴斯德的这位发言人说。
2、Sanofi and other drugmakers annually produce about 300 million doses of seasonal flu vaccines, the kind used for annual flu shots.───赛诺菲和其它的制药企业每年生产3亿支季节性感冒疫苗--那种每年注射一次的疫苗。
3、Visitors must be accompanied by someone from Sanofi.───访客必须在赛诺菲·安万特公司员工的陪同下才可以进入。
4、Sanofi spokeswoman Emmy Tsui said the company was "committed to the safe and effective use of Eligard" and was reviewing the FDA request.───赛诺菲发言人艾美.奖翠表示，该公司正按照FDA的要求，“致力于醋酸亮丙瑞林使用的安全性和有效性研究”。
5、Sanofi said the acquisition chase is getting more competitive as industry players face the same set of problems.───赛诺菲表示，由于制药业厂商面临同样的问题，收购竞逐变得越来越激烈。
6、France's Sanofi-Aventis is carrying out large clinical trials of an oral drug called teriflunomide.───法国制药公司赛诺菲-安万特也在就一种口服药物特立氟胺开展大型临床试验。
7、Buy stock in Sanofi.───购买赛诺菲的股票。
8、Just yesterday, Sanofi-Aventis said it was abandoning its drug Acomplia, which had been approved in Europe to treat obesity.───就在昨天，赛诺菲安万特宣布放弃其药物Acomplia，其已获欧洲批准用于治疗肥胖症。
9、Analysts believe Sanofi could be waiting for a final safety review for TroVax, due in the next few months.───分析家相信赛诺菲在等待关于TroVax的最终安全评估，该评估将在近几个月公布。
1、Indeed, a spokesman for Sanofi's own vaccine unit, Sanofi Pasteur, says it could probably produce both types in parallel for a time, before ramping up full-scale production of a swine-flu vaccine.
2、The drug companies Pfizer, Sanofi - Aventis and Nektar Therapeutics developed it.
3、In 2007, HHS awarded Sanofi a $77.4 million contract to retrofit that site for preparedness for a flu pandemic.
4、Earlier on Monday, the two companies said in a regulatory filing that they had entered into a nondisclosure agreement, allowing Genzyme to open its books to Sanofi.
5、Today, sanofi pasteur reinvests some 17 percent of its revenues into research and development.